Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
23.85
+0.06 (0.25%)
Aug 14, 2026, 1:30 PM EDT - Market open
Biodesix Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 102.94 | 88.5 | 71.32 | 49.09 | 38.21 | 54.51 | |
Revenue Growth | 34.46% | 24.08% | 45.30% | 28.46% | -29.89% | 19.64% |
Cost of Revenue | 18.01 | 16.72 | 15.57 | 13.01 | 14.15 | 30.52 |
Gross Profit | 84.93 | 71.78 | 55.75 | 36.08 | 24.06 | 23.99 |
Selling, General & Admin | 93.23 | 87.55 | 80.45 | 67.39 | 61.46 | 50.52 |
Research & Development | 12.28 | 12 | 9.56 | 9.99 | 13.1 | 12.79 |
Operating Expenses | 105.51 | 99.55 | 90.01 | 77.38 | 74.56 | 63.31 |
Operating Income | -20.58 | -27.77 | -34.26 | -41.3 | -50.51 | -39.32 |
Interest Expense | -8.09 | -7.72 | -8.26 | -9.54 | -8.07 | -4.51 |
Interest & Investment Income | 0.33 | - | - | - | - | - |
Other Non Operating Income (Expenses) | 0.6 | 0.32 | 0.07 | -1.27 | 0.19 | -0.01 |
EBT Excluding Unusual Items | -27.74 | -35.16 | -42.45 | -52.1 | -58.39 | -43.84 |
Asset Writedown | -0.03 | -0.11 | -0.24 | -0.04 | -0.08 | - |
Other Unusual Items | - | - | -0.25 | - | -6.98 | 0.68 |
Pretax Income | -27.76 | -35.27 | -42.93 | -52.15 | -65.45 | -43.16 |
Net Income | -27.76 | -35.27 | -42.93 | -52.15 | -65.45 | -43.16 |
Net Income to Common | -27.76 | -35.27 | -42.93 | -52.15 | -65.45 | -43.16 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 9 | 8 | 6 | 4 | 2 | 1 |
Shares Outstanding (Diluted) | 9 | 8 | 6 | 4 | 2 | 1 |
Shares Change | 21.27% | 16.71% | 57.59% | 95.03% | 53.86% | 465.63% |
EPS (Basic) | -3.13 | -4.67 | -6.64 | -12.70 | -31.09 | -31.54 |
EPS (Diluted) | -3.13 | -4.67 | -6.64 | -12.70 | -31.09 | -31.54 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -20.24 | -23.53 | -51.88 | -45.79 | -48.27 | -30.46 |
Free Cash Flow Per Share | -2.28 | -3.12 | -8.02 | -11.15 | -22.93 | -22.27 |
Gross Margin | 82.50% | 81.11% | 78.17% | 73.50% | 62.96% | 44.01% |
Operating Margin | -19.99% | -31.37% | -48.03% | -84.13% | -132.17% | -72.14% |
Profit Margin | -26.97% | -39.85% | -60.19% | -106.23% | -171.27% | -79.18% |
Free Cash Flow Margin | -19.66% | -26.59% | -72.74% | -93.28% | -126.32% | -55.89% |
EBITDA | -15.01 | -22.1 | -28.49 | -37.97 | -46.91 | -36.14 |
EBITDA Margin | -14.58% | -24.97% | -39.94% | -77.35% | -122.76% | -66.31% |
D&A For EBITDA | 5.58 | 5.67 | 5.77 | 3.33 | 3.6 | 3.18 |
EBIT | -20.58 | -27.77 | -34.26 | -41.3 | -50.51 | -39.32 |
EBIT Margin | -19.99% | -31.37% | -48.03% | -84.13% | -132.17% | -72.14% |